Loading...
Market
Story
Illumina to Spin Off Grail in June, Retains 14.5 Percent Stake
Jun 3, 2024, 11:05 PM
Illumina Inc. has officially announced the spin-off of its cancer test subsidiary, Grail. The board of directors approved the spin-off, marking the end of a nearly four-year-long saga. As part of the divestment, Illumina will issue Grail shares to its investors while retaining a 14.5 percent stake in the company. Additionally, the board declared a spin-off dividend of Grail shares. The spin-off is set to be completed in June.
View original story
Similar markets
Google • 25%
Microsoft • 25%
Amazon • 25%
Other • 25%
Media company • 33%
Technology company • 33%
No major acquisition • 34%
BHP • 25%
Rio Tinto • 25%
Vale • 25%
Glencore • 25%
With a financial institution • 33%
With a tech company • 33%
No major partnership • 33%